Exact Mass: 488.2444

Exact Mass Matches: 488.2444

Found 17 metabolites which its exact mass value is equals to given mass value 488.2444, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Jamaicamide B

(E,9E)-9-(chloromethylidene)-N-[(E)-3-methoxy-5-[(2S)-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-enyl]-6-methyltetradec-4-en-13-ynamide

C27H37ClN2O4 (488.2442)


   

7-Sulfocholic acid

(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyl-9-(sulfooxy)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O8S (488.2444)


7-Sulfocholic acid is a naturally occurring bile acid sulfate conjugate that has been identified in human bile (PMID: 7320139) and human urine. (PMID: 3584362). In mice significantly less cholic acid 7-sulfate (5-7\\%) is present in bladder bile and small intestine than in the cecum, colon, or feces (>80\\%). (PMID: 954753). 7-Sulfocholic acid is a naturally occurring bile acid sulfate conjugate that has been identified in human bile (PMID: 7320139) and human urine. (PMID: 3584362)

   

Sulfocholic acid

Sulfocholic acid

C24H40O8S (488.2444)


CONFIDENCE standard compound; INTERNAL_ID 293

   

3a-Sulfate-7a,12a-(OH)2-5b-cholanic acid

3alpha-Sulfooxy-7alpha,12alpha-dihydroxy-5beta-cholan-24-oic acid

C24H40O8S (488.2444)


BA-143-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-143-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

SCA - Sulfocholic acid

SCA - Sulfocholic acid

C24H40O8S (488.2444)


   

(4R)-4-((3R,5R,7R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,7R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O8S (488.2444)


   

(R)-4-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O8S (488.2444)


   

(3a,5b,7a,12a), 3,12-dihydroxy-7-(sulfooxy)-Cholan-24-oic acid

(3a,5b,7a,12a), 3,12-dihydroxy-7-(sulfooxy)-Cholan-24-oic acid

C24H40O8S (488.2444)


   

(3a,5b,7a,12a)-3,7-dihydroxy-12-(sulfooxy)cholan-24-oic acid

(3a,5b,7a,12a)-3,7-dihydroxy-12-(sulfooxy)cholan-24-oic acid

C24H40O8S (488.2444)


   

7-Sulfocholic acid

3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid 7-sulfate

C24H40O8S (488.2444)


   

Cholic acid 3-sulfate

Cholic acid 3-sulfate

C24H40O8S (488.2444)


   

(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-7-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-7-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O8S (488.2444)


   

(E,9E)-9-(chloromethylidene)-N-[(E)-3-methoxy-5-[(2S)-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-enyl]-6-methyltetradec-4-en-13-ynamide

(E,9E)-9-(chloromethylidene)-N-[(E)-3-methoxy-5-[(2S)-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-enyl]-6-methyltetradec-4-en-13-ynamide

C27H37ClN2O4 (488.2442)


   

2,4-dihydroxy-6-[12-(sulfooxy)heptadecyl]benzoic acid

2,4-dihydroxy-6-[12-(sulfooxy)heptadecyl]benzoic acid

C24H40O8S (488.2444)


   

(4e,9e)-9-(chloromethylidene)-n-[(3e)-3-methoxy-5-(2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-1-yl]-6-methyltetradec-4-en-13-ynimidic acid

(4e,9e)-9-(chloromethylidene)-n-[(3e)-3-methoxy-5-(2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-1-yl]-6-methyltetradec-4-en-13-ynimidic acid

C27H37ClN2O4 (488.2442)


   

9-(chloromethylidene)-n-[3-methoxy-5-(2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-1-yl]-6-methyltetradec-4-en-13-ynimidic acid

9-(chloromethylidene)-n-[3-methoxy-5-(2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-1-yl]-6-methyltetradec-4-en-13-ynimidic acid

C27H37ClN2O4 (488.2442)


   

2,4-dihydroxy-6-[(12s)-12-(sulfooxy)heptadecyl]benzoic acid

2,4-dihydroxy-6-[(12s)-12-(sulfooxy)heptadecyl]benzoic acid

C24H40O8S (488.2444)